Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Buy
2,124
+13
+0.6% +$4.45K 0.17% 86
2026
Q1
$743K Sell
2,111
-14
-0.7% -$4.99K 0.18% 84
2025
Q4
$696K Buy
2,125
+1
+0% +$317 0.18% 79
2025
Q3
$600K Buy
2,124
+2
+0.1% +$580 0.16% 85
2025
Q2
$593K Buy
2,122
+32
+2% +$9.06K 0.17% 85
2025
Q1
$651K Sell
2,090
-3,851
-65% -$1.14M 0.2% 82
2024
Q4
$1.55M Sell
5,941
-904
-13% -$268K 0.5% 55
2024
Q3
$2.21M Sell
6,845
-265
-4% -$86.7K 0.73% 45
2024
Q2
$2.22M Sell
7,110
-815
-10% -$239K 0.81% 40
2024
Q1
$2.25M Sell
7,925
-1,138
-13% -$333K 0.91% 38
2023
Q4
$2.61M Sell
9,063
-832
-8% -$227K 1.23% 28
2023
Q3
$2.66M Buy
9,895
+625
+7% +$156K 1.49% 15
2023
Q2
$2.06M Buy
9,270
+2,747
+42% +$637K 1.18% 19
2023
Q1
$1.58M Buy
+6,523
New +$1.6M 1.02% 19

Other funds holding AMGN

Channel Wealth's AMGN Position: Q2 2026 in Review

Channel Wealth increased its Amgen (AMGN) stake by 0.62% in Q2 2026, buying an estimated $4.45K and bringing the position to 2,124 shares worth $769K. The position accounts for 0.17% of the portfolio, ranked #86.

Channel Wealth first reported a position in AMGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.66M in Q3 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Channel Wealth held 2,124 shares of Amgen worth $769K as of Q2 2026.
  • Channel Wealth bought 13 Amgen shares in Q2 2026, an estimated $4.45K.
  • Amgen made up 0.17% of Channel Wealth's portfolio in Q2 2026, its #86 holding.
  • Channel Wealth first reported a position in Amgen in Q1 2023 and has held it in 14 quarters since.
  • Channel Wealth's Amgen position peaked at $2.66M in Q3 2023.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Channel Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.